Export 3 results:
Author Title Type [ Year(Asc)]
Filters: Author is Amegashie, Cyrille  [Clear All Filters]
2019
C. W. Woods, Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., DeRaad, D. E. Poer, Amanna, I. J., Slifka, M. K., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C., and Walter, E. B., “An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.”, Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
N. G. Rouphael, Hurwitz, S. J., Hart, M., Beck, A., Anderson, E. J., Deye, G., Osborn, B., Cai, S. Yi, Focht, C., Amegashie, C., Bowlin, T. L., Brooks, J., and Mulligan, M. J., “Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.”, Antimicrob Agents Chemother, vol. 63, no. 9, 2019.
2018
G. Miller, Schaefer, H., Yoder, S., Miller, R., Winokur, P., Kotloff, K., Klassen, D., Wierzbicki, M., Amegashie, C., and Edwards, K., “A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.”, Transpl Infect Dis, vol. 20, no. 3, p. e12874, 2018.